IDEXX Laboratories, Inc. (IDXX)
USD 410.76
(-3.82%)
USD 410.76
(-3.82%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 947.88 Million USD | -29.7% |
| 2022 | 1.34 Billion USD | 45.97% |
| 2021 | 923.7 Million USD | 1.68% |
| 2020 | 908.48 Million USD | -8.02% |
| 2019 | 987.67 Million USD | -1.26% |
| 2018 | 1 Billion USD | -20.68% |
| 2017 | 1.26 Billion USD | 4.73% |
| 2016 | 1.2 Billion USD | 2.91% |
| 2015 | 1.17 Billion USD | 30.15% |
| 2014 | 899 Million USD | 109.85% |
| 2013 | 428.39 Million USD | 99.72% |
| 2012 | 214.5 Million USD | -12.95% |
| 2011 | 246.41 Million USD | 84.89% |
| 2010 | 133.28 Million USD | 7.58% |
| 2009 | 123.88 Million USD | -20.83% |
| 2008 | 156.47 Million USD | 98.87% |
| 2007 | 78.68 Million USD | 1004.32% |
| 2006 | 7.12 Million USD | 1193.1% |
| 2005 | 551 Thousand USD | -67.26% |
| 2004 | 1.68 Million USD | 31.48% |
| 2003 | 1.28 Million USD | 31.55% |
| 2002 | 973 Thousand USD | -88.39% |
| 2001 | 8.38 Million USD | -1.09% |
| 2000 | 8.47 Million USD | 135.33% |
| 1999 | 3.6 Million USD | -61.7% |
| 1998 | 9.4 Million USD | 129.27% |
| 1997 | 4.1 Million USD | 36.67% |
| 1996 | 3 Million USD | 76.47% |
| 1995 | 1.7 Million USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 873.89 Million USD | -6.52% |
| 2024 Q2 | 1.06 Billion USD | -0.1% |
| 2024 Q1 | 1.06 Billion USD | 12.77% |
| 2023 Q4 | 947.88 Million USD | -6.96% |
| 2023 FY | 947.88 Million USD | -29.7% |
| 2023 Q3 | 1.01 Billion USD | -1.64% |
| 2023 Q2 | 1.03 Billion USD | -13.88% |
| 2023 Q1 | 1.2 Billion USD | -10.79% |
| 2022 Q1 | 1.28 Billion USD | 38.96% |
| 2022 Q4 | 1.34 Billion USD | -10.47% |
| 2022 FY | 1.34 Billion USD | 45.97% |
| 2022 Q3 | 1.5 Billion USD | 9.22% |
| 2022 Q2 | 1.37 Billion USD | 7.43% |
| 2021 Q2 | 905.06 Million USD | -9.48% |
| 2021 FY | 923.7 Million USD | 1.68% |
| 2021 Q4 | 923.7 Million USD | -4.1% |
| 2021 Q3 | 963.17 Million USD | 6.42% |
| 2021 Q1 | 999.81 Million USD | 10.05% |
| 2020 Q4 | 908.48 Million USD | -8.29% |
| 2020 FY | 908.48 Million USD | -8.02% |
| 2020 Q3 | 990.55 Million USD | -10.46% |
| 2020 Q2 | 1.1 Billion USD | -12.55% |
| 2020 Q1 | 1.26 Billion USD | 28.08% |
| 2019 Q3 | 1 Billion USD | -2.81% |
| 2019 FY | 987.67 Million USD | -1.26% |
| 2019 Q4 | 987.67 Million USD | -1.95% |
| 2019 Q2 | 1.03 Billion USD | -8.22% |
| 2019 Q1 | 1.12 Billion USD | 12.89% |
| 2018 FY | 1 Billion USD | -20.68% |
| 2018 Q4 | 1 Billion USD | -1.64% |
| 2018 Q3 | 1.01 Billion USD | -2.23% |
| 2018 Q2 | 1.04 Billion USD | 2.32% |
| 2018 Q1 | 1.01 Billion USD | -19.39% |
| 2017 Q1 | 1.26 Billion USD | 5.13% |
| 2017 FY | 1.26 Billion USD | 4.73% |
| 2017 Q4 | 1.26 Billion USD | -2.27% |
| 2017 Q3 | 1.29 Billion USD | -1.11% |
| 2017 Q2 | 1.3 Billion USD | 3.08% |
| 2016 Q4 | 1.2 Billion USD | 10.76% |
| 2016 Q3 | 1.08 Billion USD | -5.95% |
| 2016 FY | 1.2 Billion USD | 2.91% |
| 2016 Q2 | 1.15 Billion USD | -5.41% |
| 2016 Q1 | 1.22 Billion USD | 4.44% |
| 2015 Q3 | 1.14 Billion USD | 4.11% |
| 2015 Q4 | 1.17 Billion USD | 2.45% |
| 2015 Q2 | 1.09 Billion USD | 4.52% |
| 2015 FY | 1.17 Billion USD | 30.15% |
| 2015 Q1 | 1.04 Billion USD | 16.74% |
| 2014 Q4 | 899 Million USD | 24.0% |
| 2014 Q1 | 466.14 Million USD | 8.81% |
| 2014 FY | 899 Million USD | 109.85% |
| 2014 Q3 | 725 Million USD | 35.77% |
| 2014 Q2 | 534 Million USD | 14.56% |
| 2013 Q1 | 262.26 Million USD | 22.27% |
| 2013 Q3 | 398.84 Million USD | 7.94% |
| 2013 Q4 | 428.39 Million USD | 7.41% |
| 2013 FY | 428.39 Million USD | 99.72% |
| 2013 Q2 | 369.52 Million USD | 40.9% |
| 2012 FY | 214.5 Million USD | -12.95% |
| 2012 Q1 | 257.19 Million USD | 4.37% |
| 2012 Q2 | 246.96 Million USD | -3.98% |
| 2012 Q4 | 214.5 Million USD | -8.62% |
| 2012 Q3 | 234.73 Million USD | -4.95% |
| 2011 Q1 | 130.66 Million USD | -1.97% |
| 2011 FY | 246.41 Million USD | 84.89% |
| 2011 Q4 | 246.41 Million USD | 56.32% |
| 2011 Q3 | 157.63 Million USD | 15.57% |
| 2011 Q2 | 136.4 Million USD | 4.4% |
| 2010 Q3 | 130.4 Million USD | -5.89% |
| 2010 FY | 133.28 Million USD | 7.58% |
| 2010 Q4 | 133.28 Million USD | 2.21% |
| 2010 Q2 | 138.55 Million USD | -14.62% |
| 2010 Q1 | 162.28 Million USD | 31.0% |
| 2009 Q4 | 123.88 Million USD | -16.23% |
| 2009 FY | 123.88 Million USD | -20.83% |
| 2009 Q3 | 147.88 Million USD | -7.73% |
| 2009 Q2 | 160.28 Million USD | -6.37% |
| 2009 Q1 | 171.19 Million USD | 9.4% |
| 2008 Q4 | 156.47 Million USD | -7.87% |
| 2008 Q3 | 169.85 Million USD | 3.53% |
| 2008 Q2 | 164.06 Million USD | 12.2% |
| 2008 Q1 | 146.22 Million USD | 85.84% |
| 2008 FY | 156.47 Million USD | 98.87% |
| 2007 Q4 | 78.68 Million USD | -6.22% |
| 2007 FY | 78.68 Million USD | 1004.32% |
| 2007 Q2 | 90.53 Million USD | 10.18% |
| 2007 Q3 | 83.9 Million USD | -7.33% |
| 2007 Q1 | 82.17 Million USD | 1053.33% |
| 2006 FY | 7.12 Million USD | 1193.1% |
| 2006 Q1 | - USD | -100.0% |
| 2006 Q2 | 7.45 Million USD | 0.0% |
| 2006 Q3 | 7.29 Million USD | -2.15% |
| 2006 Q4 | 7.12 Million USD | -2.26% |
| 2005 Q4 | 551 Thousand USD | 1.66% |
| 2005 FY | 551 Thousand USD | -67.26% |
| 2005 Q1 | 526 Thousand USD | -68.75% |
| 2005 Q2 | 531 Thousand USD | 0.95% |
| 2005 Q3 | 542 Thousand USD | 2.07% |
| 2004 Q3 | 1.17 Million USD | -3.37% |
| 2004 Q4 | 1.68 Million USD | 43.36% |
| 2004 FY | 1.68 Million USD | 31.48% |
| 2004 Q1 | 1.39 Million USD | 9.14% |
| 2004 Q2 | 1.21 Million USD | -13.03% |
| 2003 FY | 1.28 Million USD | 31.55% |
| 2003 Q4 | 1.28 Million USD | 161.76% |
| 2003 Q1 | 984 Thousand USD | 1.13% |
| 2003 Q3 | 489 Thousand USD | 1.45% |
| 2003 Q2 | 482 Thousand USD | -51.02% |
| 2002 Q4 | 973 Thousand USD | 0.93% |
| 2002 Q2 | 950 Thousand USD | -88.69% |
| 2002 Q1 | 8.39 Million USD | 0.21% |
| 2002 FY | 973 Thousand USD | -88.39% |
| 2002 Q3 | 964 Thousand USD | 1.47% |
| 2001 FY | 8.38 Million USD | -1.09% |
| 2001 Q3 | 8.5 Million USD | 0.14% |
| 2001 Q2 | 8.49 Million USD | 0.26% |
| 2001 Q1 | 8.47 Million USD | 0.01% |
| 2001 Q4 | 8.38 Million USD | -1.49% |
| 2000 Q3 | 8.52 Million USD | 152.52% |
| 2000 Q4 | 8.47 Million USD | -0.62% |
| 2000 Q1 | 3.51 Million USD | -2.25% |
| 2000 FY | 8.47 Million USD | 135.33% |
| 2000 Q2 | 3.37 Million USD | -4.06% |
| 1999 Q2 | 9.5 Million USD | -3.06% |
| 1999 Q4 | 3.6 Million USD | -57.14% |
| 1999 FY | 3.6 Million USD | -61.7% |
| 1999 Q3 | 8.4 Million USD | -11.58% |
| 1999 Q1 | 9.8 Million USD | 4.26% |
| 1998 Q1 | 2.6 Million USD | -36.59% |
| 1998 Q3 | 1.5 Million USD | -40.0% |
| 1998 Q4 | 9.4 Million USD | 526.67% |
| 1998 FY | 9.4 Million USD | 129.27% |
| 1998 Q2 | 2.5 Million USD | -3.85% |
| 1997 Q4 | 4.1 Million USD | 17.14% |
| 1997 FY | 4.1 Million USD | 36.67% |
| 1997 Q1 | 4.5 Million USD | 50.0% |
| 1997 Q2 | 4.5 Million USD | 0.0% |
| 1997 Q3 | 3.5 Million USD | -22.22% |
| 1996 FY | 3 Million USD | 76.47% |
| 1996 Q4 | 3 Million USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | 3 Million USD | 0.0% |
| 1996 Q1 | - USD | -100.0% |
| 1995 Q4 | 1.7 Million USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | 1.7 Million USD | 0.0% |
| 1995 Q3 | 1.7 Million USD | 0.0% |
| 1995 Q2 | 1.7 Million USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | -977.785% |
| Prenetics Global Limited | 2.36 Million USD | -39905.267% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -26164.339% |
| CareDx, Inc | 34.22 Million USD | -2669.878% |
| Exact Sciences Corporation | 2.55 Billion USD | 62.897% |
| Exagen Inc. | 23.72 Million USD | -3895.953% |
| Inotiv, Inc. | 417.64 Million USD | -126.96% |
| Guardant Health, Inc. | 1.35 Billion USD | 29.982% |
| Biodesix, Inc. | 60.69 Million USD | -1461.813% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -710481.356% |
| Precipio, Inc. | 1.11 Million USD | -84835.484% |
| iSpecimen Inc. | 196.24 Thousand USD | -482910.946% |
| Natera, Inc. | 441.99 Million USD | -114.456% |
| Aspira Women's Health Inc. | 2.26 Million USD | -41730.538% |
| Standard BioTools Inc. | 98.21 Million USD | -865.156% |
| 23andMe Holding Co. | 76.51 Million USD | -1138.816% |
| Castle Biosciences, Inc. | 15.31 Million USD | -6091.248% |
| Personalis, Inc. | 48.96 Million USD | -1835.95% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -222407.042% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -76480.274% |
| OpGen, Inc. | 13.04 Million USD | -7166.953% |
| T2 Biosystems, Inc. | 49.49 Million USD | -1814.986% |
| Myriad Genetics, Inc. | 145 Million USD | -553.71% |
| ICON Public Limited Company | 3.93 Billion USD | 75.932% |
| NeoGenomics, Inc. | 611.67 Million USD | -54.964% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -26164.339% |
| RadNet, Inc. | 1.49 Billion USD | 36.432% |
| MDxHealth SA | 41.26 Million USD | -2197.056% |
| Psychemedics Corporation | 2.29 Million USD | -41148.042% |
| Illumina, Inc. | 2.26 Billion USD | 58.095% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | -907.643% |
| DarioHealth Corp. | 29.54 Million USD | -3108.693% |
| Fulgent Genetics, Inc. | 14.9 Million USD | -6258.623% |
| Sera Prognostics, Inc. | 1.85 Million USD | -50916.146% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -240232.858% |
| OPKO Health, Inc. | 326.56 Million USD | -190.259% |
| Medpace Holdings, Inc. | 142.12 Million USD | -566.948% |
| Neogen Corporation | 906.23 Million USD | -4.595% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -108671.688% |
| Prenetics Global Limited | 2.36 Million USD | -39905.267% |
| Mainz Biomed B.V. | 7.42 Million USD | -12673.32% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -59944.127% |
| Trinity Biotech plc | 67.42 Million USD | -1305.787% |
| Neuronetics, Inc. | 62.47 Million USD | -1417.239% |
| Sotera Health Company | 2.32 Billion USD | 59.267% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -59944.127% |